Abstract
De novo enzyme design traditionally begins with "theozymes"—idealized arrangements of catalytic residues around a reaction's transition state. However, translating these atomic-level descriptions into stable protein scaffolds has been hampered by the need to pre-calculate backbone geometries and pre-specify residue positions in a sequence. We present RFdiffusion2, a generative AI method that enables enzyme design directly from sequence-agnostic, atomic-resolution descriptions of functional groups. By eliminating the requirement for inverse rotamer generation and fixed sequence indexing, RFdiffusion2 achieved a 100% success rate on a diverse 41-case in silico benchmark, significantly outperforming previous state-of-the-art methods (39%). Experimental validation across three diverse catalytic sites—including a zinc metallohydrolase with a $k_{cat}/K_M$ of $53,000 \, M^{-1}s^{-1}$—demonstrates that RFdiffusion2 can produce highly active catalysts with remarkably high hit rates, typically requiring the screening of fewer than 96 sequences.
Introduction
Nature employs enzymes to catalyze complex chemical transformations with unparalleled precision and efficiency. For decades, computational biologists have sought to replicate this capability through de novo design. The standard workflow involves defining a theoretical active site (a theozyme) and then searching for or building a protein structure capable of supporting that site.
Despite recent advances in deep learning for protein design, two primary bottlenecks have persisted. First, the Backbone Bottleneck: most models require a pre-defined protein backbone, forcing designers to use "inverse rotamer sampling" to guess where a backbone might exist to support specific side-chain atoms. Second, the Sequence Bottleneck: designers typically must specify the exact sequence positions of catalytic residues, which severely limits the structural diversity the model can explore. RFdiffusion2 addresses these challenges by shifting the generative process to the atomic level.
Methodology: Atomic-Resolution Generative Design
RFdiffusion2 evolves the RosettaFold Diffusion architecture to handle the complexities of enzyme active sites without the constraints of traditional scaffolding methods.
Atomic Motif Conditioning
Unlike its predecessors, which often scaffolded entire residues or required backbone coordinates, RFdiffusion2 can be conditioned on "atomic motifs." This allows the model to take the specific coordinates of functional group atoms as input. The model then simultaneously predicts the optimal side-chain rotamers, the corresponding backbone, and the surrounding protein fold that best stabilizes the site.
Sequence-Agnostic Scaffolding
One of the most significant shifts in RFdiffusion2 is the move to "unindexed" residues. By providing the model with the coordinates of active site atoms without assigning them to specific positions in the sequence (e.g., Residue 50 or 120), the model is free to determine the most evolutionarily and physically plausible sequence placement. This flexibility allows the model to discover novel folds that human experts might overlook.
Technical Innovations
- Flow Matching: The authors transitioned from standard diffusion to a flow matching framework, providing a more stable training objective and allowing the model to learn effectively from randomly initialized weights.
- Controllable Burial (RASA): To ensure the active site is appropriately positioned for substrate access, the model allows designers to specify the Relative Accessible Surface Area (RASA), controlling whether a site is buried in the core or exposed on the surface.
- The ORI Token: A specialized pseudo-atom (the ORI token) was introduced to provide a "prior belief" regarding the center of the protein relative to the ligand, helping the model orient the active site within the scaffold's geometry.
Results and Discussion
In Silico Benchmarking
To evaluate the model, the authors introduced the Atomic Motif Enzyme (AME) benchmark, featuring 41 diverse active sites across five Enzyme Commission (EC) classes. This benchmark represents a significant increase in complexity over previous standards. RFdiffusion2 successfully generated valid scaffolds for all 41 cases (100%), whereas the original RFdiffusion model only succeeded in 16 of 41 cases (39%). Notably, the model's performance remained robust even as the complexity of the active site—measured by the number of disconnected sequence segments or "residue islands"—increased.
Experimental Validation
The true test of de novo design lies in laboratory activity. RFdiffusion2 designs were tested for four distinct reactions, yielding high hit rates and impressive kinetics:
- Zinc Metallohydrolase: Designed for 4MU-Phenylacetate, these enzymes achieved a $k_{cat}/K_M$ of $53,000 \, M^{-1}s^{-1}$, representing an improvement of several orders of magnitude over previous de novo zinc-based designs.
- Cysteine Hydrolase: These designs achieved a $k_{cat}/K_M$ of $250 \, M^{-1}s^{-1}$.
- Retroaldolase: The team identified four active variants from a small library.
In all experimental cases, active catalysts were identified by screening fewer than 96 sequences, a testament to the model's precision and the high quality of the generated scaffolds.
Conclusion
RFdiffusion2 marks a paradigm shift in enzyme design by moving from residue-level approximations to atomic-level precision. By automating the placement of functional groups and the generation of supporting backbones, it removes the need for expert-driven "inverse rotamer" heuristics. While these designed enzymes do not yet match the hyper-efficiency of natural enzymes—likely due to the simplicity of current theozymes—RFdiffusion2 provides a powerful foundation for the future of synthetic biology and chemical engineering. Future iterations focusing on the co-design of second-shell interactions and electrostatic environments may soon close the gap between human-made and natural catalysts.
Summary updated